Clinical trial
Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer
NCT00212095 · National University Hospital, Singapore, Other · Completed
Key facts
| NCT number | NCT00212095 |
|---|---|
| Title | Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer |
| Official title | Phase II Study of Docetaxel Combined With Ketoconazole in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast Tumor |
| Lead sponsor | National University Hospital, Singapore, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Breast Cancer |
| Intervention type | Drug |
| Interventions | docetaxel and ketoconazole |
| Enrollment | 30 |
| Start date | Jun 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | Jun 1, 2012 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 1, 2012 |
| Countries | Singapore |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: